| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody and immunotherapy in diffuse large B-cell lymphoma
|
Barraclough, Allison
|
|
|
60 |
5 |
p. 338-345
|
artikel
|
| 2 |
Biological heterogeneity in diffuse large B-cell lymphoma
|
Hilton, Laura K.
|
|
|
60 |
5 |
p. 267-276
|
artikel
|
| 3 |
CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
|
Kinoshita, Hannah
|
|
|
60 |
5 |
p. 329-337
|
artikel
|
| 4 |
DLBCL arising from indolent lymphomas: How are they different?
|
Parry, Erin M.
|
|
|
60 |
5 |
p. 277-284
|
artikel
|
| 5 |
Effective sequencing of chimeric antigen receptor T-cell therapy in the treatment of LBCL in 2023
|
Ryan, Christine E.
|
|
|
60 |
5 |
p. 322-328
|
artikel
|
| 6 |
Epidemiology and etiology of diffuse large B-cell lymphoma
|
Wang, Sophia S.
|
|
|
60 |
5 |
p. 255-266
|
artikel
|
| 7 |
Evidence-based management of primary and secondary CNS lymphoma
|
Khwaja, Jahanzaib
|
|
|
60 |
5 |
p. 313-321
|
artikel
|
| 8 |
Integration of PET in DLBCL
|
Lewis, Katharine L
|
|
|
60 |
5 |
p. 291-304
|
artikel
|
| 9 |
Introduction to series: Diffuse large B-cell lymphoma
|
Smith, Sonali M.
|
|
|
60 |
5 |
p. 251-254
|
artikel
|
| 10 |
Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities
|
Brem, Elizabeth A.
|
|
|
60 |
5 |
p. 285-290
|
artikel
|
| 11 |
outside front cover, PMS 8883 metallic AND 4/C
|
|
|
|
60 |
5 |
p. CO1
|
artikel
|
| 12 |
Second-line treatment of diffuse large B‐cell lymphoma: Evolution of options
|
Fabbri, N.
|
|
|
60 |
5 |
p. 305-312
|
artikel
|
Tijdschrift beschrijving